Endocrine cancer constitutes a term and simultaneously a definition of a type of cancer, that is common in American literature whereas so far absent in European nomenclature. Detailed analysis of scientific programs of European endocrinological and oncological congresses proves that also these societies do not mention this type of cancer. To change this unfavorable situation a new clinical platform called European Task Group for Endocrine Cancer (ETEC), working under the auspices of the ESE Clinical Committee, has been created.
The lecture will discuss the features characteristic for endocrine cancer and why it is worthy to look for them. Molecular features that join malignant tumors in a one separate group named endocrine cancer” will be analyzed. We also attempt to answer the question how the molecular characteristic of endocrine cancer may influence our clinical practice, both its diagnostic and therapeutic aspects.
17 - 19 Feb 2016
European Society of Endocrinology